Literature DB >> 15748706

Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.

Svetlana N Rylova1, Freidoun Albertioni, Gunnar Flygh, Staffan Eriksson.   

Abstract

Nucleoside reverse transcriptase inhibitor (NRTI) treatment of HIV is associated with complications, including lipodystrophy (LD) and myopathy. Inhibition of mitochondrial DNA polymerase and depletion of mtDNA by NRTI triphosphates are believed to be key mechanisms in NRTI toxicity. Here, we determined the activities and mRNA levels of deoxynucleoside kinases (dNK) and 5'-nucleotidases (5'-NT) controlling the rate-limiting step in intracellular phosphorylation of NRTIs in cell models representing adipose, muscle tissue and peripheral blood cells using specific assays and Taqman RT-PCR. In vitro phosphorylation of 3'-azido-2',3'-dideoxythymidine (AZT) and 2',3'-didehydro-2',3'-dideoxythymidine (d4T) in extracts was also determined. 3T3-L1 adipocytes showed similar activity of mitochondrial thymidine kinase-2 (TK2) and deoxyguanosine kinase (dGK) but 3- to 36-fold lower levels of cytosolic deoxycytidine kinase (dCK), thymidine kinase-1 (TK1) and thymidine monophosphate kinase (TMPK) and higher levels of deoxyribonucleotidase activity compared to proliferating 3T3-L1. dCK, dGK and TK2 activities correlated with their mRNA levels in proliferating, resting and differentiating 3T3-L1. Differentiated L6 myoblasts had lower activities of cytosolic dNK's and TMPK, higher dGK and similar TK2 and deoxyribonucleotidases (dNT) activities compared to proliferating myoblasts. TK2 was the limiting dNK activity while dGK was predominant in adipocytes and myocytes. Activity profiles revealed limited capacity to phosphorylate dThd and dCyd in adipocytes and myocytes compared to proliferating cells and CEM lymphocytes. Phosphorylation of AZT and d4T was low in adipocytes and myocytes, and the presence of these analogs inhibited the phosphorylation of dThd by TK2 suggesting that mitochondrial toxicity of some NRTIs in adipocytes and myocytes is due to the depletion of normal mitochondrial dNTP pools.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748706     DOI: 10.1016/j.bcp.2004.12.010

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Mitochondrial dysfunction in white adipose tissue.

Authors:  Christine M Kusminski; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2012-07-10       Impact factor: 12.015

2.  Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.

Authors:  Xinhui Chen; Jose R Castillo-Mancilla; Sharon M Seifert; Kevin B McAllister; Jia-Hua Zheng; Lane R Bushman; Samantha MaWhinney; Peter L Anderson
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  In silico study supports the efficacy of a reduced dose regimen for stavudine.

Authors:  Selwyn J Hurwitz; Raymond F Schinazi
Journal:  Antiviral Res       Date:  2011-08-22       Impact factor: 5.970

4.  Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals.

Authors:  Seyed H Hosseini; James J Kohler; Chad P Haase; Nina Tioleco; Tami Stuart; Erin Keebaugh; Tomika Ludaway; Rodney Russ; Elgin Green; Robert Long; Liya Wang; Staffan Eriksson; William Lewis
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

5.  Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5'-diphosphate in the presence or absence of reductant.

Authors:  Erin Artin; Jun Wang; Gregory J S Lohman; Kenichi Yokoyama; Guixue Yu; Robert G Griffin; Galit Bar; JoAnne Stubbe
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

6.  Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.

Authors:  Akihiko Saitoh; Richard H Haas; Robert K Naviaux; Neurita G Salva; Justine K Wong; Stephen A Spector
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

7.  Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors.

Authors:  Kaleb C Lund; Kendall B Wallace
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-25       Impact factor: 4.219

8.  BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.

Authors:  Faye Wang; Oliver P Flint
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

9.  Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes.

Authors:  Saray Quintero-Fabián; Daniel Ortuño-Sahagún; Manuel Vázquez-Carrera; Rocío Ivette López-Roa
Journal:  Mediators Inflamm       Date:  2013-12-26       Impact factor: 4.711

10.  In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.

Authors:  Stefanie Bulst; Elke Holinski-Feder; Brendan Payne; Angela Abicht; Sabine Krause; Hanns Lochmüller; Patrick F Chinnery; Maggie C Walter; Rita Horvath
Journal:  Mol Genet Metab       Date:  2012-05-03       Impact factor: 4.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.